To deepen our understanding of biopharma leaders’ perspectives on what it takes to be a “Best Practice Organization” (BPO), we interviewed 24 CEOs, Chief Commercialization Officers, franchise leads, and other cross-functional commercialization executives in Q2 of 2024. The conversations addressed topics such as
- The critical challenges affecting biopharma companies’ ability to function as a BPO
- Definitions of what makes a company a BPO
- Key success factors to becoming a BPO
In this paper, we share their perspectives on what companies can do to operate as a Best Practice Organization, which we define as a company that consistently demonstrates exceptional performance, effectiveness, and efficiency to achieve its vision, mission, and strategic objectives.
